Pleural Diseases
Conditions
Brief summary
This study aims to evaluate the diagnostic efficacy, safety, and clinical outcomes of thoracoscopic pleural biopsy in the management of pleural diseases.
Interventions
This intervention aims to evaluate the diagnostic efficacy, safety, and clinical outcomes of thoracoscopic pleural biopsy in the management of pleural diseases.
Sponsors
Study design
Eligibility
Inclusion criteria
* Patients with suspected pleural disease who have been referred for thoracoscopic pleural biopsy * Age: Adults aged 18 years and older * Patients should have undergone necessary preoperative evaluations, including imaging studies (e.g., chest X-ray, CT scan) that indicate a need for biopsy.
Exclusion criteria
* Contraindications to Thoracoscopic Biopsy: Patients with contraindications to thoracoscopic biopsy * Infeasibility of Procedure: Patients with anatomical or physiological factors that make thoracoscopic biopsy technically unfeasible or unsafe (e.g., severe pleural adhesions or distorted anatomy). * Alternative Diagnoses: Patients who have been definitively diagnosed with a condition that does not require thoracoscopic biopsy for further evaluation. * Pregnancy: Pregnant women may be excluded due to potential risks to the fetus and the need for specific procedural considerations. * Inability to Provide Consent: Patients who are unable to provide informed consent due to cognitive impairment, language barriers, or other reasons. * Participation in Concurrent Studies: Patients currently participating in other clinical studies that could interfere with the outcomes of this study or affect their eligibility.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| early postoperative follow up for thoracoscopic pleural biopsy in the management of pleural diseases. | 3 days after procedure | return to daily activity |
Countries
Egypt